PHARMACY

Report: FastCare to open at Meijer

BY Gina Acosta

FastCare is opening a retail health clinic inside the new Meijer in Sturgis, S.D., in September. (Sturgis Journal)

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

NACDS joins 37 Congress leaders in supporting TRICARE cost-saving dispensing pilot

BY Michael Johnsen

ARLINGTON, Va. – The National Association of Chain Drug Stores on Wednesday publicly thanked the 37 members of the U.S. House of Representatives who have sent a letter to House and Senate negotiators, urging them to advance a TRICARE pilot program as part of the FY2017 National Defense Authorization Act.

U.S. Reps. Dave Loebsack, D-Iowa, Buddy Carter, R-Ga., and Peter Welch, D-Vt., led the effort on this letter, which was sent to the chairmen and ranking members of the House and Senate Armed Services Committees – those who are heading the effort to work out differences between the two chambers’ versions of the NDAA.

Contained in the House’s version of the bill, the “Pilot Program for Prescription Drug Acquisition Cost Parity in the TRICARE Pharmacy Benefits Program” would provide military families and veterans with the choice of how they get their medications and also would lower program costs.

“NACDS appreciates the work of Congressman Dave Loebsack, Congressman Buddy Carter and Congressman Peter Welch to advance this important pilot program,” stated Steven Anderson, NACDS president and CEO. “This pilot has the potential to preserve the choice of military families and veterans, to reduce Defense Department costs and to boost patient health by maintaining access to the pharmacist-patient relationship.”

The pilot program in effect would allow the Department of Defense to access lower pricing for prescriptions dispensed at community pharmacies.

“TRICARE beneficiaries have seen a number of changes to their prescription drug plan over the last few years, including brand name maintenance medications being dispensed via mail order or at Military Treatment Facilities and increased prescription copayments. These changes have not only impacted beneficiary access and health, but have also resulted in shifting health care costs to the Medicare program,” the House members wrote.

“The pilot program … is a sensible approach to maintaining beneficiary choice and access while at the same time lowering [DoD] costs. Currently, the DoD is able to purchase medications that are dispensed through mail order and [MTFs] at a much lower costs than for drugs dispensed in the retail setting, in some cases as much as 32% lower. The pilot program would allow the DoD to purchase prescription drugs dispensed in the retail setting at the lowest rate available to the Department, thereby eliminating those cost differences," the letter continued. "The pilot would also produce savings by lowering the costs paid in administration fees by the DoD for prescription drugs. It is believed the DoD currently pays three times as much in per prescription administrative fees to dispense prescriptions through mail than the retail setting. Allowing patients to maintain treatment from their retail pharmacy, including small business pharmacies, will result in lower overall administrative fees, preserve beneficiary choice and allow access to valuable in-person consultations with their pharmacies.”

The House and Senate will need to pass an identical version of the NDAA before it can be sent to the President for consideration and for signing into law.
 
 
 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Namzaric gets FDA approval for expanded label

BY David Salazar
SILVER SPRING, Md. — Allergan and Adamas Pharmaceuticals on Tuesday announced an expanded label for their Namzaric (memantine and donepezil hydrochlorides). It can now be used by patients with moderate to severe Alzheimer’s disease. 
 
Patients currently stabilized on Aricept (donepezil HCL, 10 mg) can begin combination therapy with Namzaric. 
 
"Namzaric offers the benefits of combining two products that each work differently  to treat moderate to severe Alzheimer's disease while at the same time reducing the number of pills a patient and their caregivers need to administer each day," Allergan chief medical officer Dr. Gavin Corcoran, said. "At Allergan, we're proud to continue developing products and supporting new programs that can help patients and their caregivers as they navigate this complex disease."
 
The expanded label also comes with two new dosage strengths, which the companies said will be available in September. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?